Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • 2'3'-cGAMP (sodium salt): Benchmark STING Agonist for cGA...

    2026-02-25

    2'3'-cGAMP (sodium salt): Benchmark STING Agonist for cGAS-STING Pathway Research

    Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenous, high-affinity STING agonist synthesized by cGAS in response to cytosolic double-stranded DNA detection. It directly binds and activates the STING protein with nanomolar affinity (Kd = 3.79 nM) to induce type I interferon signaling (APExBIO, product page). Its delivery in lipid nanoparticles enhances cellular uptake and antitumor activity in preclinical cancer models (Shaji et al., 2024). 2'3'-cGAMP is water-soluble (≥7.56 mg/mL), stable at −20°C, and widely used for STING pathway research, immunotherapy, and antiviral studies. This article details its biological rationale, mechanism, validated applications, and integration strategies for laboratory workflows.

    Biological Rationale

    2'3'-cGAMP (sodium salt) is the principal cyclic dinucleotide second messenger generated by cyclic GMP-AMP synthase (cGAS) upon detection of cytosolic double-stranded DNA in mammalian cells (Shaji et al., 2024). Its production is a core event in the cGAS-STING signaling pathway, serving as a molecular bridge between DNA sensing and innate immune activation. Endogenous 2'3'-cGAMP is distinguished by its 2'-5', 3'-5' mixed phosphodiester linkages, which confer high specificity and affinity toward the STING receptor (Related: Dual role in cancer radiotherapy resistance; this article expands by providing updated in vivo benchmarking data and workflow parameters). Activation of STING by 2'3'-cGAMP leads to phosphorylation of TBK1 and IRF3, ultimately driving type I interferon (IFN-β) transcription and secretion. This axis is essential for initiating antiviral states, modulating tumor microenvironments, and enhancing immunotherapy efficacy (Related: Strategic context of cGAS-STING translational mechanisms; here, we provide quantitative benchmarks and assay integration data).

    Mechanism of Action of 2'3'-cGAMP (sodium salt)

    2'3'-cGAMP is synthesized by cGAS from ATP and GTP after cGAS binds cytosolic dsDNA. The resulting cyclic dinucleotide binds directly to the STING protein (stimulator of interferon genes), an endoplasmic reticulum-resident receptor. This interaction (Kd = 3.79 nM) induces a conformational change in STING, facilitating its trafficking from the ER to the Golgi apparatus (APExBIO, B8362 datasheet). Upon activation, STING recruits and activates TANK-binding kinase 1 (TBK1), which phosphorylates interferon regulatory factor 3 (IRF3). Phosphorylated IRF3 dimerizes and translocates to the nucleus, promoting transcription of type I interferon genes and pro-inflammatory cytokines. This cascade establishes an antiviral and immunostimulatory state in affected and neighboring cells (Related: Strategic guidance for translational use; this article enumerates validated cellular and in vivo benchmarks).

    Evidence & Benchmarks

    • 2'3'-cGAMP binds human STING with a Kd of 3.79 nM, indicating superior affinity compared to other cyclic dinucleotides (APExBIO product data, link).
    • Lipid nanoparticle-encapsulated 2'3'-cGAMP (cGAMP-LNP) increases cytosolic delivery, cellular uptake, and enables robust anti-tumor responses in a syngeneic mouse pancreatic cancer model (Shaji et al., 2024).
    • 2'3'-cGAMP induces type I interferon (IFN-β) expression within hours of delivery in both cell culture and murine models of cancer (Shaji et al., 2024).
    • In aqueous solutions, 2'3'-cGAMP (sodium salt) is stable and soluble at concentrations ≥7.56 mg/mL; it is insoluble in ethanol and DMSO (APExBIO, product page).
    • Its molecular weight (718.37 Da) and formula (C20H22N10Na2O13P2) allow precise quantification and reproducibility in cell-based assays (APExBIO, link).
    • 2'3'-cGAMP-mediated STING activation is validated as a gold standard for innate immunity and antiviral signaling assays (Related: overview of assay scenarios; this article provides molecular and translational benchmarks).

    Applications, Limits & Misconceptions

    2'3'-cGAMP (sodium salt) is widely used in immunology, oncology, and virology research. Its primary applications include:

    • Dissecting the cGAS-STING pathway in cellular and animal models.
    • Screening small molecules or biologics targeting STING for immunotherapy development.
    • Modeling type I interferon induction and downstream immune responses.
    • Evaluating tumor microenvironment modulation and radiosensitization strategies.

    Common Pitfalls or Misconceptions

    • 2'3'-cGAMP (sodium salt) is not membrane-permeable; efficient cytosolic delivery (e.g., via electroporation or lipid nanoparticles) is required for in vivo and ex vivo studies (Shaji et al., 2024).
    • It does not activate STING in all species equally; sequence variants in STING may alter sensitivity, particularly in non-mammalian models (APExBIO).
    • The compound is unstable above 4°C and should be stored at −20°C for maximal shelf life.
    • 2'3'-cGAMP does not directly activate adaptive immune cells (e.g., T cells); its effects are mediated via myeloid and stromal cell STING activation.
    • It is not suitable for ethanol or DMSO-based delivery due to insolubility.

    Workflow Integration & Parameters

    For optimal experimental reproducibility, 2'3'-cGAMP (sodium salt) from APExBIO (SKU: B8362) should be reconstituted in sterile water at concentrations up to 7.56 mg/mL. For cell-based assays, delivery via transfection reagents, electroporation, or encapsulation in lipid nanoparticles is recommended. Standard assays include IFN-β ELISA, qPCR for interferon-stimulated genes, and viability/cytotoxicity readouts. The compound should be stored at −20°C, protected from light and repeated freeze-thaw cycles.

    For benchmarking and troubleshooting innate immune assays, see this scenario-based guide (this article adds quantitative affinity and delivery data for broader model organisms).

    Conclusion & Outlook

    2'3'-cGAMP (sodium salt) is a rigorously validated, high-affinity STING agonist and a critical tool for dissecting DNA sensing and innate immune signaling. Its benchmark status is underpinned by robust in vitro and in vivo data, including recent advances in nanoparticle-based delivery that enhance its translational relevance for cancer immunotherapy (Shaji et al., 2024). The B8362 kit from APExBIO provides reliable, reproducible results for immunology and virology research. Future directions include optimizing targeted delivery platforms and extending validation to additional disease models and species. For ordering and technical data, visit the 2'3'-cGAMP (sodium salt) product page.